Stock 6998 GENOR BIOPHARMA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Genor Biopharma Holdings Limited

Equities

6998

KYG3871A1004

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:25 27/05/2024 BST 		5-day change 1st Jan Change
1.36 HKD +3.82% Intraday chart for Genor Biopharma Holdings Limited -0.73% +14.29%
03-27 Genor Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-14 China's Drug Regulator Accepts Genor Biopharma's New Breast Cancer Drug Application; Shares Up 7% MT

Business Summary

Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.

Number of employees: 104

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 516,454,238 341,226,078 ( 66.07 %) 3,786,684 ( 0.7332 %) 66.07 %

Shareholders

NameEquities%Valuation
Hillhouse Capital Group Ltd.
24.63 %
126,239,103 24.63 % 20 M $
WALVAX BIOTECHNOLOGY CO., LTD.
7.329 %
37,560,998 7.329 % 6 M $
Temasek Capital Pte Ltd.
5.689 %
29,157,348 5.689 % 5 M $
Feng Guo
1.149 %
5,891,375 1.149 % 941 560 $
China Asset Management (Hong Kong) Ltd.
0.003512 %
18,000 0.003512 % 2 877 $

Company contact information

Genor Biopharma Holdings Ltd.

Pudong New District 1690 Zhangheng Road

201203, Shanghai

+86 400 788 6695

http://www.genorbio.com
address Genor Biopharma Holdings Limited(6998)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GENOR BIOPHARMA HOLDINGS LIMITED Stock Genor Biopharma Holdings Limited
+14.29% 85.33M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+12.30% 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.15% 106B
BIONTECH SE Stock BioNTech SE
-8.14% 23.4B
ARGENX SE Stock argenx SE
-0.29% 21.78B
GENMAB A/S Stock Genmab A/S
-9.28% 18.09B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.70% 16.72B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.33% 15.97B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.80% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.03% 11.67B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6998 Stock
  4. Company Genor Biopharma Holdings Limited